Faculty profile

Tzu-Fei Wang

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Ottawa

Tzu-Fei Wang

Associate Professor

Department of Medicine

Faculty of Medicine

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
97 publications in the last five years, latest in 2026.
Senior (last) author on 13 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

116

Publications

1,860

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Direct Oral Anticoagulants Drug-To-Drug Interactions Hemorrhage Allophones Cancer Patients Francophones Health Administrative Data Language Barriers

Latest papers

Association Between Bariatric Surgery and the Long‐Term Risk for Venous Thromboembolism: A Population‐Based Matched Cohort Study
American Journal of Hematology · 2026
A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study
American Journal of Hematology · 2026 · first author
Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE)
Blood advances · 2026

All 116 publications

Latest funding

Clonal Hematopoiesis in Venous Thromboembolism: Advancing Precision in Risk Prediction and Treatment Outcomes
CIHR · 2026 · Co-investigator
$485,774
Development of a risk stratification score for recurrent venous thromboembolism and clinically-relevant bleeding in patients with cancer-associated venous thromboembolism. CAN-CATCH Study
CIHR · 2024 · Co-investigator
$424,575
Virtual care utilization and impact among individuals with breast cancer on systemic therapy: a population-based retrospective cohort study
CIHR · 2024 · Co-investigator
$100,000

All 14 grants and awards

116 publications.

Association Between Bariatric Surgery and the Long‐Term Risk for Venous Thromboembolism: A Population‐Based Matched Cohort Study

Simard C, Le Gal G, Lazo‐Langner A, Tagalakis V, Grewal K, Nguyen F, Wang T, Siegal DM, Anvari M, Doumouras AG

American Journal of Hematology20262 citations

DOI: 10.1002/ajh.70186

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Wang T, Yeo E, Gross PL, Séguin C, Wu C, Shivakumar S, Mallick R, Delluc A, D'Astous J, Kimpton M

American Journal of Hematology2026First author

DOI: 10.1002/ajh.70127

Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE)

Shaw JR, Gray H, Xu Y, Le Gal G, Wang T-F, Khalife R, Siegal DM, Castellucci LA, Delluc A, Grussé M

Blood advances2026

DOI: 10.1182/bloodadvances.2026020203

Impact of concurrent antiplatelet use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial.

Saad M, Wang TF, Mallick R, Hill D, Lazo-Langner A, Tagalakis V, Wells PS, Carrier M

Thrombosis research2026

DOI: 10.1016/j.thromres.2026.109681 PMID: 41985366

Recurrent VTE in patients with thrombophilia after stopping anticoagulation: a systematic review and meta-analysis.

Vrotniakaite-Bajerciene K, Wang TF, Sabri E, Shorr R, Angelillo-Scherrer A, Le Gal G, Carrier M

Blood advances2026

DOI: 10.1182/bloodadvances.2026020623 PMID: 42448302

Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.

Hamulyák EN, Wang TF, Kreuziger LB, Iyengar V, Carney BJ, Hoeben A, Özdemir BC, Cordova Serrano RD, Sanfilippo KM, Rozenblatt S, Beenen LFM, Yust-Katz S, Halperin E, Arad A, Lubetsky A, Carrier M, Massat B, Büller HR, Spectre G, Zwicker JI, Leader A, ABC Study Group

Blood vessels, thrombosis & hemostasis2026

DOI: 10.1016/j.bvth.2026.100140 PMID: 41852714

Venous Thromboembolism Prophylaxis and Postoperative Outcomes in Persons with Bleeding Disorders Undergoing Major Surgery: A Canadian Pilot Feasibility Study.

Uminski K, Sun HW, Goodyear D, Rydz N, Cowley L, Wang TF, Wells P, Khalife R

TH open : companion journal to thrombosis and haemostasis2026

DOI: 10.1055/a-2859-7625 PMID: 42368627

Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers.

Roy DC, Wang TF, Mallick R, Burger D, Carrier M, Wells P, Hawken S

European heart journal2026

DOI: 10.1093/eurheartj/ehaf1002 PMID: 41384379

Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis.

Khan F, Tritschler T, Marx CE, Lanting V, Rochwerg B, Tran A, Fernando SM, Lorenzetti DL, Wunsch H, Holodinsky J, Fiest K, Stelfox HT, Delluc A, Fergusson DA, Le Gal G, Wells PS, Wang TF, Sanfilippo K, van Es N, Schrag D, Connors JM, Carrier M

European heart journal2026

DOI: 10.1093/eurheartj/ehaf453 PMID: 40579365

Beyond API-CAT: the remaining challenges of extended anticoagulation for cancer-associated thrombosis.

Di Nisio M, Wang TF

European heart journal. Cardiovascular pharmacotherapy2026Senior author

DOI: 10.1093/ehjcvp/pvag054 PMID: 42481162

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Tzu-Fei Wang

Research

Latest papers

Latest funding

Association Between Bariatric Surgery and the Long‐Term Risk for Venous Thromboembolism: A Population‐Based Matched Cohort Study

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE)

Impact of concurrent antiplatelet use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial.

Recurrent VTE in patients with thrombophilia after stopping anticoagulation: a systematic review and meta-analysis.

Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.

Venous Thromboembolism Prophylaxis and Postoperative Outcomes in Persons with Bleeding Disorders Undergoing Major Surgery: A Canadian Pilot Feasibility Study.

Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers.

Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysis.

Beyond API-CAT: the remaining challenges of extended anticoagulation for cancer-associated thrombosis.

Frequent collaborators

Marc Carrier

Deborah Siegal

Alan Tinmouth

Deborah Siegal

Lisa Duffett

Philip Wells

Yan Xu

Steven Hawken

Alejandro Lazo-Langner

James Demetrios Douketis

Dylan Burger

Vicky Tagalakis

Miriam Kimpton

Sudeep Shivakumar

Jeffrey Weitz

Rebecca Auer

Peter Tanuseputro

Caroline Hamm

Chantal Backman

Alexandre Tran

Sam Schulman

Rick Ikesaka

Peter Tanuseputro

Dar Dowlatshahi

Yue Chen

Natasha Kekre

Joseph Shaw

Timothy Ramsay

Krystal Kehoe MacLeod

Jessalyn Holodinsky

Marc Carrier

Corey Tsang

Aliza Moledina

Colleen Webber

Na Li

Keerat Grewal

Kednapa Thavorn

Mehran Anvari

Ari Doumouras

Steffan Frosi Stella